The Pharmacy Times® C. Difficile Resource Center is a comprehensive resource for clinical news and expert insights on issues related to Clostridium difficile, a bacteria that causes colitis, a serious inflammation of the colon.
April 1st 2024
Scientists hypothesize that fecal microbiota transplant restores the recipient’s gut microbiota to an environment that mimics the healthy donor’s microbiota
Toxin Driving Drug-Resistant Strains of C Diff Mapped, Identifying Starting Point for a Cure
March 29th 2021Through investigating a type of toxin released by the most dangerous strains of C. diff, researchers now have a map for developing drugs that can block the toxin and prevent the bacteria from entering human cells.
Read More
Treatment for C difficile Shows Promising Potential in First-in-Human Phase 1 Trial
October 6th 2019A first-in-human trial evaluating the safety, pharmacokinetics, and fecal microbiome effects of a novel DNA polIIIC inhibitor demonstrated the antibacterial’s promise as a potential treatment alternative to vancomycin for the treatment of Clostridioides difficile.
Read More
C. Difficile Prevalence Underscores Pharmacist's Antibiotic Stewardship Role
February 25th 2015The US Centers for Disease Control and Prevention today reported that nearly half a million Clostridium difficile infections occurred in a single year, highlighting a critical need for improved antibiotic use.
Read More